176 related articles for article (PubMed ID: 26147064)
1. A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan.
Bhaskar U; Hickey AM; Li G; Mundra RV; Zhang F; Fu L; Cai C; Ou Z; Dordick JS; Linhardt RJ
Biotechnol Prog; 2015; 31(5):1348-59. PubMed ID: 26147064
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial one-pot chemoenzymatic synthesis of heparin.
Bhaskar U; Li G; Fu L; Onishi A; Suflita M; Dordick JS; Linhardt RJ
Carbohydr Polym; 2015 May; 122():399-407. PubMed ID: 25817684
[TBL] [Abstract][Full Text] [Related]
3. E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor.
Wang Z; Ly M; Zhang F; Zhong W; Suen A; Hickey AM; Dordick JS; Linhardt RJ
Biotechnol Bioeng; 2010 Dec; 107(6):964-73. PubMed ID: 20717972
[TBL] [Abstract][Full Text] [Related]
4. Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy.
Guerrini M; Naggi A; Guglieri S; Santarsiero R; Torri G
Anal Biochem; 2005 Feb; 337(1):35-47. PubMed ID: 15649373
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharide.
Huang H; Liu X; Lv S; Zhong W; Zhang F; Linhardt RJ
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7877-85. PubMed ID: 27079575
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli K5 heparosan fermentation and improvement by genetic engineering.
Wang Z; Dordick JS; Linhardt RJ
Bioeng Bugs; 2011; 2(1):63-7. PubMed ID: 21636991
[TBL] [Abstract][Full Text] [Related]
7. Polyelectrolyte multilayer assembly as a function of pH and ionic strength using the polysaccharides chitosan and heparin.
Boddohi S; Killingsworth CE; Kipper MJ
Biomacromolecules; 2008 Jul; 9(7):2021-8. PubMed ID: 18564872
[TBL] [Abstract][Full Text] [Related]
8. Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.
Wang Z; Yang B; Zhang Z; Ly M; Takieddin M; Mousa S; Liu J; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2011 Jul; 91(1):91-9. PubMed ID: 21484210
[TBL] [Abstract][Full Text] [Related]
9. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
Volpi N
Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
[TBL] [Abstract][Full Text] [Related]
10. Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin.
Xiong J; Bhaskar U; Li G; Fu L; Li L; Zhang F; Dordick JS; Linhardt RJ
J Biotechnol; 2013 Sep; 167(3):241-7. PubMed ID: 23835156
[TBL] [Abstract][Full Text] [Related]
11. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.
Naggi A; Torri G; Casu B; Oreste P; Zoppetti G; Li JP; Lindahl U
Semin Thromb Hemost; 2001 Oct; 27(5):437-43. PubMed ID: 11668413
[TBL] [Abstract][Full Text] [Related]
12. Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides.
Roy A; Miyai Y; Rossi A; Paraswar K; Desai UR; Saijoh Y; Kuberan B
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129765. PubMed ID: 33069832
[TBL] [Abstract][Full Text] [Related]
13. Analysis of E. coli K5 capsular polysaccharide heparosan.
Ly M; Wang Z; Laremore TN; Zhang F; Zhong W; Pu D; Zagorevski DV; Dordick JS; Linhardt RJ
Anal Bioanal Chem; 2011 Jan; 399(2):737-45. PubMed ID: 20407891
[TBL] [Abstract][Full Text] [Related]
14. Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin.
Wang Z; Li J; Cheong S; Bhaskar U; Akihiro O; Zhang F; Dordick JS; Linhardt RJ
J Biotechnol; 2011 Dec; 156(3):188-96. PubMed ID: 21925548
[TBL] [Abstract][Full Text] [Related]
15. Addressing endotoxin issues in bioengineered heparin.
Suwan J; Torelli A; Onishi A; Dordick JS; Linhardt RJ
Biotechnol Appl Biochem; 2012; 59(6):420-8. PubMed ID: 23586950
[TBL] [Abstract][Full Text] [Related]
16. One-hour screening of adulterated heparin by simplified peroxide digestion and fast RPIP-LC-MS(2).
Li H; Wickramasekara S; Nemes P
Anal Chem; 2015 Aug; 87(16):8424-32. PubMed ID: 26168275
[TBL] [Abstract][Full Text] [Related]
17. The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides.
Mummery RS; Mulloy B; Rider CC
Glycobiology; 2007 Oct; 17(10):1094-103. PubMed ID: 17673511
[TBL] [Abstract][Full Text] [Related]
18. Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies.
Deng JQ; Li Y; Wang YJ; Cao YL; Xin SY; Li XY; Xi RM; Wang FS; Sheng JZ
Nat Commun; 2024 May; 15(1):3755. PubMed ID: 38704385
[TBL] [Abstract][Full Text] [Related]
19. Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests.
Brustkern AM; Buhse LF; Nasr M; Al-Hakim A; Keire DA
Anal Chem; 2010 Dec; 82(23):9865-70. PubMed ID: 21069966
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel structure in heparin generated by sequential oxidative-reductive treatment.
Beccati D; Roy S; Lech M; Ozug J; Schaeck J; Gunay NS; Zouaoui R; Capila I; Kaundinya GV
Anal Chem; 2012 Jun; 84(11):5091-6. PubMed ID: 22624650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
